Michael E Ray

Summary

Affiliation: Saint Louis University School of Medicine
Country: USA

Publications

  1. pmc Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
    Jeffrey Vainshtein
    Department of Radiation Oncology, University of Michigan Hospital, Ann Arbor, MI, USA
    Radiat Oncol 7:82. 2012
  2. pmc Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial
    Michael E Ray
    Radiology Associates of Appleton, Appleton, WI 54911, USA
    J Natl Cancer Inst 101:228-36. 2009

Collaborators

  • Gerald E Hanks
  • William U Shipley
  • Jeffrey Vainshtein
  • Karin B Olson
  • Howard M Sandler
  • Dan Normolle
  • Kathryn Masi
  • Daniel A Hamstra
  • Charlie Pan
  • Eyad Abu-Isa
  • Dale W Litzenberg

Detail Information

Publications2

  1. pmc Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
    Jeffrey Vainshtein
    Department of Radiation Oncology, University of Michigan Hospital, Ann Arbor, MI, USA
    Radiat Oncol 7:82. 2012
    ....
  2. pmc Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial
    Michael E Ray
    Radiology Associates of Appleton, Appleton, WI 54911, USA
    J Natl Cancer Inst 101:228-36. 2009
    ..We evaluated distant metastasis and general clinical treatment failure as potential surrogates for prostate cancer-specific survival by use of data from the Radiation Therapy and Oncology Group 92-02 randomized trial...